Can anti-cancer drugs be used as an effective therapy for the treatment of Alzheimer’s disease?

Background Worldwide, around 50 million people have dementia. According to the World Health Organization reports, this number is expected to increase threefold by 2050. Alzheimer’s disease (AD) is the most common type of dementia, which is characterised by deterioration in cognition and behaviour. The underlying aetiopathogenesis of AD is still little understood. The amyloid plaques theory and tau hyperphosphorylation are […]

Read More…

Save Frankincense: Overharvesting of a precious commodity and approaches to ensure sustainability

Frankincense resin is highly sought after and as a consequence, frankincense-bearing trees are being overharvested.

In Somaliland, a northern area of Somalia that operates as an independent country, many of the population rely on frankincense for income. Frankincense is a resin derived from the Boswellia tree. However, the trees are being overharvested, and locals have found themselves in a poverty trap. Despite a huge increase in the price of frankincense on the global market, harvesters […]

Read More…

Using technology to improve needle procedures

Inthis article: Dr Gabor Fichtinger and Dr Jan Fritz have been collaborating to create a computerised system that overlays 2D magnetic resonance images onto a patient during surgical procedures.

Dr Gabor Fichtinger is Chair of Cancer Care Ontario Research and Professor at Queen’s University School of Computing in Kingston, Ontario. His interests are in computer-assisted surgery and interventions. Dr Jan Fritz is the Director of Interventional MR Imaging and an Assistant Professor of Radiology and Radiological Science at Johns Hopkins University School of Medicine, Baltimore, Maryland. The two have […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION